DOCS icon

Doximity

56.29 USD
+2.07
3.82%
At close Apr 24, 4:00 PM EDT
After hours
56.38
+0.09
0.16%
1 day
3.82%
5 days
6.21%
1 month
-15.15%
3 months
-0.48%
6 months
35.74%
Year to date
5.10%
1 year
135.42%
5 years
6.21%
10 years
6.21%
 

About: Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Employees: 827

0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 10 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

255% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 33

40% more repeat investments, than reductions

Existing positions increased: 154 | Existing positions reduced: 110

25% more capital invested

Capital invested by funds: $4.95B [Q3] → $6.18B (+$1.22B) [Q4]

22% more funds holding

Funds holding: 348 [Q3] → 426 (+78) [Q4]

20% more call options, than puts

Call options by funds: $125M | Put options by funds: $104M

0% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]

0.56% less ownership

Funds ownership: 90.86% [Q3] → 90.3% (-0.56%) [Q4]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$55
2%
downside
Avg. target
$71
27%
upside
High target
$90
60%
upside

10 analyst ratings

positive
40%
neutral
60%
negative
0%
Morgan Stanley
Ricky Goldwasser
43% 1-year accuracy
6 / 14 met price target
7%upside
$60
Equal-Weight
Maintained
24 Apr 2025
Keybanc
Scott Schoenhaus
31% 1-year accuracy
12 / 39 met price target
24%upside
$70
Overweight
Maintained
16 Apr 2025
Truist Securities
Jailendra Singh
23% 1-year accuracy
8 / 35 met price target
3%upside
$58
Hold
Maintained
10 Apr 2025
Mizuho
Steven Valiquette
29% 1-year accuracy
2 / 7 met price target
15%upside
$65
Neutral
Maintained
10 Feb 2025
Goldman Sachs
David Roman
25% 1-year accuracy
5 / 20 met price target
42%upside
$80
Neutral
Maintained
10 Feb 2025

Financial journalist opinion

Based on 4 articles about DOCS published over the past 30 days

Positive
Zacks Investment Research
1 week ago
Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?
Both TEM and DOCS are technology-intensive healthcare companies leveraging artificial intelligence to enhance their platforms. Which one is a better investment?
Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?
Positive
Zacks Investment Research
3 weeks ago
5 Momentum Stocks to Buy for April Despite a Disappointing March
Five stocks have strong momentum for April. These are: APP, MRVL, DOCS, RDDT, VEEV.
5 Momentum Stocks to Buy for April Despite a Disappointing March
Neutral
Zacks Investment Research
3 weeks ago
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know
Doximity (DOCS) closed at $60.55 in the latest trading session, marking a -1.51% move from the prior day.
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know
Positive
Zacks Investment Research
4 weeks ago
3 Medical Services Industry Stocks to Buy as AI Fuels Growth
The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most.
3 Medical Services Industry Stocks to Buy as AI Fuels Growth
Positive
Zacks Investment Research
1 month ago
Doximity (DOCS) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw Doximity (DOCS) settling at $62.99, representing a +0.35% change from its previous close.
Doximity (DOCS) Beats Stock Market Upswing: What Investors Need to Know
Positive
Investors Business Daily
1 month ago
Spotify, Rubrik Lead Five Growth Stocks Regaining This Key Level
Amid the market correction, few growth stocks are above their 50-day moving averages. Spotify, Rubrik lead five that have reclaimed that level.
Spotify, Rubrik Lead Five Growth Stocks Regaining This Key Level
Positive
Zacks Investment Research
1 month ago
Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat
Top-ranked stocks Doximity (DOCS), Life Time Group Holdings (LTH), Adtalem Global Education (ATGE), BioMarin Pharmaceutical (BMRN) and Iridium Communications (IRDM) are likely to beat on the bottom line in their upcoming releases.
Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat
Positive
Zacks Investment Research
1 month ago
Buy 5 High-Flying Health & Fitness Stocks Year to Date With More Upside
Five Health & Fitness stocks have strong growth potential for 2025. These are: GRMN, SFM, DOCS, LTH, VFC.
Buy 5 High-Flying Health & Fitness Stocks Year to Date With More Upside
Positive
Zacks Investment Research
1 month ago
Is Doximity (DOCS) a Solid Growth Stock? 3 Reasons to Think "Yes"
Doximity (DOCS) possesses solid growth attributes, which could help it handily outperform the market.
Is Doximity (DOCS) a Solid Growth Stock? 3 Reasons to Think "Yes"
Positive
Zacks Investment Research
1 month ago
5 Top-Ranked Stocks Poised for an Earnings Beat
Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Lyft (LYFT), Garmin (GRMN) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases.
5 Top-Ranked Stocks Poised for an Earnings Beat
Charts implemented using Lightweight Charts™